- Title: Subtitle
- MVA-BN as monkeypox vaccine for healthy and immunocompromised
- Creators
- E.T. Overton - University of AlabamaS. Lawrence - Washington University School of Medicine, Division of Infectious Diseases, St. Louis, United StatesJ. Stapleton - University of IowaH. Weidenthaler - Bavarian Nordic (Germany)D. Schmidt - Bavarian Nordic (Germany)K. Nopora - Bavarian Nordic (Germany)T. Meyer - Bavarian Nordic, Clinical Development, Martinsried, GermanyJ. Maclennan - Bavarian Nordic, Clinical Development, Martinsried, GermanyB. Koenen - Bavarian Nordic (Germany)G. Silbernagl - Bavarian Nordic, Clinical Development, Martinsried, GermanyA. Volkmann - Bavarian Nordic, Early Development, Martinsried, GermanyP. Chaplin - Bavarian Nordic (Germany)
- Resource Type
- Abstract
- Publication Details
- International journal of infectious diseases, Vol.101, pp.464-464
- DOI
- 10.1016/j.ijid.2020.09.1217
- ISSN
- 1201-9712
- eISSN
- 1878-3511
- Publisher
- Elsevier Ltd
- Language
- English
- Date published
- 12/2020
- Academic Unit
- Microbiology and Immunology; Infectious Diseases; Internal Medicine
- Record Identifier
- 9984297529302771
Abstract
MVA-BN as monkeypox vaccine for healthy and immunocompromised
International journal of infectious diseases, Vol.101, pp.464-464
12/2020
DOI: 10.1016/j.ijid.2020.09.1217
Details
Metrics
14 Record Views